Results 261 to 270 of about 5,638,461 (310)

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

Advanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin, Yimo Yan, Nikola Cesarovic, Simone Schuerle   +3 more
wiley   +1 more source

Association Between Frailty and Cognitive Impairment in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

J Nurs Scholarsh
Bui HT, Apriliyasari RW, Bui QHQ, Tsai PS.   +3 more
europepmc   +1 more source

Mitochondrial dysfunction-ferroptosis crosstalk drives renal fibrosis in chronic kidney disease. [PDF]

Ren Fail
Zeng L, Zhu L, Xu H, Li Y, Hu K.
europepmc   +1 more source

Lactate Metabolism and Protein Lactylation in Diabetic Kidney Disease: A Narrative Review. [PDF]

Diabetes Metab Syndr Obes
Sun L, Yang Y, Pan W, Zhang C, Lu J, Guo S, Zhu Y, Zhu M.   +7 more
europepmc   +1 more source

The double-edged sword effect of estrogen in kidney disease and its precision modulation. [PDF]

Front Endocrinol (Lausanne)
Zhang J, Lyu J, Deng M, Han J, Wang Q, Song J, Zheng R, Bai Z.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Acute Kidney Disease to Chronic Kidney Disease

Critical Care Clinics, 2021
Acute kidney injury (AKI) and chronic kidney disease are common interconnected syndromes that represent a public health problem. Acute kidney disease (AKD) is defined as the post-AKI status of acute or subacute kidney damage/dysfunction manifested by persistence of AKI beyond 7 to 90 days after the initial AKI diagnosis.
Javier A, Neyra, Lakhmir S, Chawla
openaire   +2 more sources